A victory by Democratic presidential candidate Joe Biden in the November election could significantly change tax bills for a slew of Americans. Here's what you need to know.

Read more →

(Bloomberg) — Biogen Inc.’s experimental Alzheimer’s disease therapy failed to gain support from a panel of U.S. Food and Drug Administration advisers on Friday, putting the drug at a crossroads as the agency weighs approval.The outside experts voted 8 to 1, with 2 undecided, that data from a single clinical trial with positive results was…

Read more →

Nio Inc – ADR (NYSE: NIO) has gained about 39% this week, taking the year-to-date gains to over 950%. After going past the psychological barrier of $30 late last week, the stock moved above the $40 level Wednesday.$420 Vs. $42: Tesla Inc (NASDAQ: TSLA) CEO Elon Musk shrugged off the astronomical gains in his own…

Read more →

(Bloomberg Opinion) — It’s hard to focus on anything besides the election and pandemic. But one of the most important drug debates in years is taking place this week, and it has nothing to do with President Donald Trump or Covid-19.On Friday, a panel of experts convened by the Food and Drug Administration will review the possible approval…

Read more →

Second Quarter Revenue Grew 62% YoY to $45.5MCustomer Locations continued to grow reaching over 80,000 locations globally GTV grew 56% YoY to $8.

Read more →

Betting markets continue to give the former vice president the inside track, while Trump’s chances of being reelected appear less probable. 

Read more →

(Bloomberg Opinion) — Jack Ma is a very busy man. China’s richest man has been busy launching the world’s biggest IPO. He has been busy preparing for Alibaba Group Holding Ltd.’s grandest four-day Double Eleven shopping extravaganza. And yet two weeks ago, Ma somehow found the time to opine on China’s banking system at a high-profile financial forum…

Read more →

Pfizer Inc. (NYSE: PFE) will manage distribution of its COVID-19 vaccine on its own rather than through the U.S. government's designated coordinator, but officials question whether the U.S. has an adequate supply of medical-grade freezers at the point of use for vaccines requiring storage at ultra-cold temperatures.The Centers for Disease Control and Prevention in August…

Read more →

Miller Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. The Opportunity Equity Fund posted a return of 13.01% for the quarter (net of fees), outperforming its benchmark, the S&P 500 Index which returned 8.93% in the same quarter. You should check out Miller Value Partners’ top…

Read more →